Quarterly report pursuant to Section 13 or 15(d)

Earnings Per Share (Tables)

v3.22.1
Earnings Per Share (Tables)
9 Months Ended
Mar. 31, 2022
Notes Tables  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

The following table reflects the calculation of basic and diluted earnings per share (in thousands, except per share amounts):

    

Quarter Ended

Nine Months Ended

March 31, 

March 31, 

    

2022

    

2021

2022

    

2021

Earnings per share – basic:

Net earnings, including noncontrolling interest

$

60,144

 

$

45,402

$

201,184

 

$

124,941

Less net earnings (loss) attributable to noncontrolling interest

(595)

 

(380)

(9,343)

 

(509)

Net earnings attributable to Bio-Techne

$

60,739

$

45,782

$

210,527

$

125,450

Income allocated to participating securities

 

(25)

 

(27)

 

(95)

 

(77)

Income available to common shareholders

$

60,714

$

45,755

$

210,432

$

125,373

Weighted-average shares outstanding – basic

 

39,272

 

38,856

 

39,225

 

38,693

Earnings per share – basic

$

1.55

$

1.18

$

5.36

$

3.24

Earnings per share – diluted:

 

  

 

  

 

  

 

  

Net earnings, including noncontrolling interest

$

60,144

$

45,402

$

201,184

$

124,941

Less net earnings (loss) attributable to noncontrolling interest

(595)

(380)

(9,343)

(509)

Net earnings attributable to Bio-Techne

$

60,739

$

45,782

$

210,527

$

125,450

Income allocated to participating securities

 

(25)

 

(27)

 

(95)

 

(77)

Income available to common shareholders

$

60,714

$

45,755

$

210,432

$

125,373

Weighted-average shares outstanding – basic

 

39,272

 

38,856

 

39,225

 

38,693

Dilutive effect of stock options and restricted stock units

 

1,697

 

1,820

 

1,848

 

1,612

Weighted-average common shares outstanding – diluted

 

40,969

 

40,676

 

41,073

 

40,305

Earnings per share – diluted

$

1.48

$

1.12

$

5.12

$

3.11